Medicine guide

Humira 20 mg/0.2 ml

As listed in the register: Humira 20 mg/0.2 ml, Injektionslösung in einer Fertigspritze

20 mg/0.2 ml ·

  • Prescription only
  • Cancer treatments and immune-system medicines
Active substance
Adalimumabum
Made by
AbbVie AG

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

  • Rheumatoide Arthritis, früh diagnostizierte rheumatoide Arthritis, Psoriasis-Arthritis, Ankylosierende Spondylitis (Morbus Bechterew), Morbus Crohn, Plaque-Psoriasis, Colitis ulcerosa, Polyartikuläre juvenile idiopathische Arthritis, Hidradenitis suppurativa, Uveitis

From the official label · 2026-09-30 · Swissmedic

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

SpainNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

Details

Made byAbbVie AG
Active substanceAdalimumabum
Used inCancer treatments and immune-system medicines
Strength20 mg/0.2 ml
ClassificationL04AB04 · Cancer treatments and immune-system medicines
Dispensing (as stated by the register)Abgabekategorie B
Name in the registerHumira 20 mg/0.2 ml, Injektionslösung in einer Fertigspritze
Packs2 Fertigspritze(n)
Zulassungsnummer56221
Dosisstärke3

Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician

Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.